5. Landlord shall provide a tenant finish allowance of $54,990.00 to be applied toward interior improvements. Tenant shall bear the entire cost of any interior improvements to be installed by Landlord in the premises in excess of the finish-out...Lease Agreement • May 12th, 2000 • Luminex Corp • Services-commercial physical & biological research
FORM OFUnderwriting Agreement • March 27th, 2000 • Luminex Corp • Services-commercial physical & biological research • New York
FORM OF AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • August 14th, 2002 • Luminex Corp • Services-commercial physical & biological research • Texas
BY AND AMONGAsset Purchase Agreement • September 10th, 2002 • Luminex Corp • Services-commercial physical & biological research • Delaware
EXHIBIT 10.18 LEASE AGREEMENTLease Agreement • November 13th, 2001 • Luminex Corp • Services-commercial physical & biological research • Texas
EXHIBIT 4.2 THIS WARRANT AND ANY SHARES ACQUIRED UPON THE EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AMENDED, OR ANY STATE SECURITIES LAWS AND MAY NOT BE TRANSFERRED, SOLD OR OTHERWISE DISPOSED OF UNLESS...Luminex Corp • February 7th, 2000 • New York
EXHIBIT 10.2 LUMINEX CORPORATION RESTRICTED STOCK AGREEMENT THIS RESTRICTED STOCK AGREEMENT (this "Agreement") dated as of May 15, 2004, is entered into between Luminex Corporation, a Delaware corporation (the "Company"), and Patrick J. Balthrop (the...Restricted Stock Agreement • May 18th, 2004 • Luminex Corp • Services-commercial physical & biological research • Texas
EXHIBIT 10.3 SUBLEASE AGREEMENT This Sublease is made as of the 2nd day of May, 2002 at Travis County, Texas by and between LUMINEX CORPORATION (herein, "Sublandlord") and AMERICAN INNOVATIONS, LTD. (herein, "Subtenant"). Sublandlord is the Lessee...Sublease Agreement • August 14th, 2002 • Luminex Corp • Services-commercial physical & biological research
EXHIBIT 10.18 THIRD AMENDMENT TO THE MANAGEMENT SERVICES AGREEMENT THIS THIRD AMENDMENT TO THE MANAGEMENT SERVICES AGREEMENT dated August 12, 2002 is entered into and effective this 11th day of December, 2003 by and between Luminex Corporation, a...Management Services Agreement • March 15th, 2004 • Luminex Corp • Services-commercial physical & biological research
LUMINEX CORPORATION AND WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of May 13, 2020 3.00% Convertible Senior Notes due 2025Indenture • May 13th, 2020 • Luminex Corp • Surgical & medical instruments & apparatus • New York
INDENTURE dated as of May 13, 2020 between LUMINEX CORPORATION, a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and WILMINGTON TRUST, NATIONAL ASSOCIATION, a national banking association, as trustee (the “Trustee,” as more fully set forth in Section 1.01).
Exhibit 10.15 FORM OF EMPLOYMENT AGREEMENTEmployment Agreement • March 13th, 2000 • Luminex Corp • Services-commercial physical & biological research • Texas
Dealer]Luminex Corp • May 13th, 2020 • Surgical & medical instruments & apparatus
The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the call option transaction entered into between [Dealer] (“Dealer”) and Luminex Corporation (“Counterparty”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. Each party further agrees that this Confirmation together with the Agreement evidence a complete binding agreement between Counterparty and Dealer as to the subject matter and terms of the Transaction to which this Confirmation relates, and shall supersede all prior or contemporaneous written or oral communications with respect thereto.
ANDRights Agreement • June 21st, 2001 • Luminex Corp • Services-commercial physical & biological research • New York
EXHIBIT 10.4 FIRST AMENDMENT TO LEASE AGREEMENT BETWEEN AETNA LIFE INSURANCE COMPANY, AS LANDLORD, AND LUMINEX CORPORATION, AS TENANT To be attached to and form a part of Lease made the 19th day of December, 2001 (which together with any amendments,...Lease Agreement • August 14th, 2002 • Luminex Corp • Services-commercial physical & biological research
EXHIBIT 10.1 CONSULTANT AGREEMENT THIS CONSULTANT AGREEMENT (the "Agreement") is effective as of the 5th day of September, 2002 (the "Effective Date"), by and between Mark B. Chandler, Ph.D. ("Consultant") and Luminex Corporation, a Delaware...Consultant Agreement • September 10th, 2002 • Luminex Corp • Services-commercial physical & biological research
1 EXHIBIT 10.13 SIXTH AMENDMENT TO LEASE AGREEMENT BETWEEN AETNA LIFE INSURANCE COMPANY, AS LANDLORD, AND LUMINEX CORPORATION, AS TENANT To be attached to and form a part of Lease made the 1st day of August, 1989 (which together with any amendments,...Lease Agreement • March 30th, 2001 • Luminex Corp • Services-commercial physical & biological research
Dealer]Luminex Corp • May 13th, 2020 • Surgical & medical instruments & apparatus • New York
The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the Warrants issued by Luminex Corporation (“Company”) to [Dealer] (“Dealer”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. Each party agrees that, as to the subject matter and terms of the Transaction to which this Confirmation relates, this Confirmation together with the Agreement (as defined below) shall supersede all prior or contemporaneous written or oral communications between Company and Dealer.
LUMINEX CORPORATION RESTRICTED SHARE AWARD AGREEMENT (DIRECTORS)Restricted Share Award Agreement • May 25th, 2006 • Luminex Corp • Services-commercial physical & biological research • Delaware
EXHIBIT 10.8 SECOND AMENDMENT TO DEVELOPMENT AND SUPPLY AGREEMENT This Second Amendment to Development and Supply Agreement ("Amendment"), effective as of June 12, 2000, is made by and between Luminex Corporation, a Delaware corporation ("LUMINEX"),...Development and Supply Agreement • March 30th, 2001 • Luminex Corp • Services-commercial physical & biological research
AGREEMENT AND PLAN OF MERGER BY AND AMONG: DIASORIN S.P.A. DIAGONAL SUBSIDIARY INC. AND LUMINEX CORPORATION DATED AS OF APRIL 11, 2021Agreement and Plan of Merger • April 12th, 2021 • Luminex Corp • Surgical & medical instruments & apparatus • Delaware
This AGREEMENT AND PLAN OF MERGER (“Agreement”) is made and entered into as of April 11, 2021 (the “Agreement Date”) by and among DiaSorin S.p.A., a società per azioni organized under the laws of the Republic of Italy (“Parent”), Diagonal Subsidiary Inc., a Delaware corporation and wholly owned indirect subsidiary of Parent (“Merger Subsidiary”), and Luminex Corporation, a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Exhibit A.
RECITALEmployment Agreement • March 15th, 2004 • Luminex Corp • Services-commercial physical & biological research • Texas
LEASE AMENDMENTLease Amendment • March 31st, 2003 • Luminex Corp • Services-commercial physical & biological research
RECITALEmployment Agreement • May 18th, 2004 • Luminex Corp • Services-commercial physical & biological research • Texas
LUMINEX CORPORATION and THE BANK OF NEW YORK TRUST COMPANY, N.A., as Trustee INDENTURE Dated as of , 2008 Providing for the Issuance of Debt SecuritiesLuminex Corp • June 16th, 2008 • Services-commercial physical & biological research • New York
THIS INDENTURE, between Luminex Corporation, a Delaware corporation (hereinafter called the “Company”) having its principal office at 12212 Technology Boulevard, Austin, Texas 78727, and The Bank of New York Trust Company, N.A., a national banking association, as trustee (hereinafter called the “Trustee”), is made and entered into as of this day of , 2008.
EXHIBIT 10.2 LUMINEX CORPORATION NON-QUALIFIED STOCK OPTION AGREEMENT THIS NON- QUALIFIED STOCK OPTION AGREEMENT (this "Agreement") is made and entered into as of this _____ day of _______________, 200__ (the "Grant Date"), by and between Luminex...Non-Qualified Stock Option Agreement • May 25th, 2006 • Luminex Corp • Services-commercial physical & biological research • Delaware
UBS SECURITIES LLC LUMINEX CORPORATION 3,500,000 Shares of Common Stock Underwriting AgreementLuminex Corp • June 25th, 2008 • Services-commercial physical & biological research • New York
Luminex Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 3,500,000 shares of common stock, par value $0.001 per share (“Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 525,000 shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are collectively herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are herein referred to as the “Stock”. The Stock, including the Shares, will have attached thereto rights (the “Rights”) to purchase Series A Junior Participating Preferred Stock. The Rights are to be issued pursuant to a Rights Agreement (the “Rights Agreement”) dated as of June 20, 2001 betw
EMPLOYMENT AGREEMENTEmployment Agreement • February 26th, 2019 • Luminex Corp • Surgical & medical instruments & apparatus • Texas
THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of March 1, 2018 (the “Effective Date”) by and between Luminex Corporation, a Delaware corporation (“Luminex”) and Eric Shapiro (“Executive”).
AGREEMENT AND PLAN OF MERGER among LUMINEX CORPORATION and COMMODORE ACQUISITION, INC. and NANOSPHERE, INC. dated as of May 15, 2016Agreement and Plan of Merger • May 16th, 2016 • Luminex Corp • Surgical & medical instruments & apparatus • Delaware
This Agreement and Plan of Merger (this “Agreement”), is entered into as of May 15, 2016, by and among Nanosphere, Inc., a Delaware corporation (the “Company”), Luminex Corporation, a Delaware corporation (“Parent”), and Commodore Acquisition, Inc., a Delaware corporation and a wholly-owned Subsidiary of Parent (“Merger Sub”). Capitalized terms used herein (including in the immediately preceding sentence) and not otherwise defined herein shall have the meanings set forth in Section 9.01 hereof.
LUMINEX CORPORATION RESTRICTED SHARE UNIT AWARD AGREEMENT (2012 LTIP)Restricted Share Unit Award Agreement • March 13th, 2012 • Luminex Corp • Surgical & medical instruments & apparatus • Delaware
THIS RESTRICTED SHARE UNIT AWARD AGREEMENT (this “Agreement”) is made and entered into as of the __ day of _____, 2012 (the “Grant Date”), between Luminex Corporation, a Delaware corporation, (together with its Subsidiaries, the “Company”), and ________________________________ (the “Grantee”). Capitalized terms not otherwise defined herein shall have the meaning ascribed to such terms in the Luminex Corporation 2012 Long Term Incentive Plan (the “LTIP”).
EMPLOYMENT AGREEMENTEmployment Agreement • February 25th, 2015 • Luminex Corp • Surgical & medical instruments & apparatus • Texas
THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of August 14, 2012 (the “Effective Date”) by and between Luminex Corporation, a Delaware corporation (“Luminex”) and Nancy M. Capezzuti (“Executive”).
LUMINEX CORPORATION NON-QUALIFIED STOCK OPTION AGREEMENTNon-Qualified Stock Option Agreement • August 7th, 2018 • Luminex Corp • Surgical & medical instruments & apparatus • Delaware
THIS NON-QUALIFIED STOCK OPTION AGREEMENT (this "Agreement") is made and entered into as of __________ (the "Grant Date"), by and between Luminex Corporation, a Delaware corporation (together with its Subsidiaries and Affiliates where applicable, the "Company"), and the person whose name is set forth on the attached Notice of Grant of Stock Options (the "Optionee"). Capitalized terms not otherwise defined herein shall have the meaning ascribed to such terms in the Luminex Corporation 2018 Equity Incentive Plan (the "Plan").
RECITALSIndemnification Agreement • August 14th, 2002 • Luminex Corp • Services-commercial physical & biological research • Delaware
RECITALEmployment Agreement • May 25th, 2005 • Luminex Corp • Services-commercial physical & biological research • Texas
Luminex Corporation 12212 Technology Blvd. Austin, TX 78727 Attn: Harriss Currie,, Chief Financial Officer Ladies and Gentlemen:Confidentiality Agreement • June 2nd, 2016 • Luminex Corp • Surgical & medical instruments & apparatus • New York
This confidentiality agreement (this “Agreement”) is entered into as of the 6th day of November, 2015, by and between Nanosphere, Inc., a Delaware corporation (the “Company”), and Luminex Corporation (“you” or “your”). In connection with your consideration of a possible negotiated transaction (the “Transaction”) with the Company, you have requested and the Company is prepared to make available to you certain Confidential Information (as defined below) regarding the Company. In consideration of your receipt of such information, you agree as follows:
WITNESSETH:Employment Agreement • March 16th, 2006 • Luminex Corp • Services-commercial physical & biological research
